This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Biomarin Pharmaceutical Inc (BMRN)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 875.49M 568.78M 180.53M 46.27M
Receivables 201.15M 117.82M 109.07M 110.93M
Inventories 199.45M 162.60M 128.70M 130.12M
Other Current Assets 17.41M 41.71M 25.51M 4.99M
Total Current Assets 1.43B 1.14B 743.46M 469.80M
Property, Plant & Equipment, Gross 752.40M 504.36M 433.60M 384.72M
Accumulated Depreciation & Depletion 228.89M 185.04M 149.12M 115.74M
Property, Plant & Equipment, Net 523.52M 319.32M 284.47M 268.97M
Intangibles 156.58M 163.15M 162.98M 180.28M
Other Non-Current Assets 164.18M 424.69M 133.68M 110.44M
Total Non-Current Assets 1.06B 1.11B 858.18M 833.88M
Liabilities & Shareholder Equity
Total Assets 2.49B 2.25B 1.60B 1.30B
Accounts Payable 36.67M 48.78M 23.99M 12.24M
Short Term Debt 0.00 0.00 23.36M 0.00
Other Current Liabilities 5.48M 3.60M 2.07M 4.07M
Total Current Liabilities 235.74M 183.27M 170.43M 94.12M
Long Term Debt 657.98M 655.57M 324.86M 348.33M
Deferred Income Taxes 0.00 0.00 33.30M 35.13M
Other Non-Current Liabilities 68.84M 69.34M 57.29M 53.05M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 726.82M 724.90M 415.45M 436.51M
Total Liabilities 962.56M 908.18M 585.88M 530.63M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 1.53B 1.34B 1.02B 773.05M
Common Par 149.00K 144.00K 126.00K 115.00K
Additional Paid In Capital 2.36B 2.06B 1.56B 1.20B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -849.77M -715.80M -539.45M -425.10M
Treasury Stock -9.70M -7.42M -6.60M -3.94M
Other Equity Adjustments 27.47M 5.02M -202.00K 4.89M
Total Capitalization 2.19B 2.00B 1.34B 1.12B
Total Equity 1.53B 1.34B 1.02B 773.05M
Total Liabilities & Stock Equity 2.49B 2.25B 1.60B 1.30B
Total Common Shares Outstanding 149.09M 143.46M 125.81M 114.79M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 146.35M 137.76M 120.27M 112.12M
Diluted Weighted Shares Outstanding 146.35M 137.76M 120.27M 112.12M
Number of Employees 1681 1341 1089 1002
Number of Part-Time Employees 0 0 0 0

BMRN Biomarin Pharmaceutical Inc

Chart of BMRN

Analysts Ratings for BMRN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 9 10 10 11
Moderate Buy 2 2 1 1
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

BMRN Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs